Allergan Aesthetics received FDA approval for Skinvive by Juvéderm for the improvement of neck appearance, marking the second cleared indication for the product line. Skinvive, a smooth, cohesive HA formulation designed for superficial dermal placement, was previously approved for chin augmentation. The neck approval broadens the injectable's clinical utility in a high-visibility zone where practitioners increasingly seek alternatives to traditional volumizers and neuromodulators.